Medicines authorised in Romania

Skyrizi

Skyrizi is a medicine containing Risankizumab, listed in the Romanian national register of medicines for human use with 7 presentations.

General information from the official register, not medical advice. Anpheros does not diagnose and does not recommend medicines. Read the package leaflet and ask your doctor or pharmacist before taking any medicine.

At a glance

Active substance
RISANKIZUMABUM
ATC code
L04AC18 Antineoplastic and immunomodulating agents
Therapeutic action
IMUNOSUPRESOARE INHIBITORI DE INTERLEUKINA
Prescription
Prescription required (register code PR)
Marketing authorisation holder
ABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIA
Manufacturer
ABBVIE S.R.L. - ITALIA
ABBVIE DEUTSCHLAND GMBH & CO. KG - GERMANIA
Pharmaceutical form
SOL. INJ. IN SERINGA PREUMPLUTA
SOL. INJ. IN STILOU INJECTOR PREUMPLUT
SOL INJ. IN CARTUS
CONC. PT. SOL. PERF.

Presentations and codes

CIM is the code of each pack in the Romanian register; the Anpheros app saves it when it recognises the box.

CIM codeFormStrengthPackPrescriptionAuthorisationShelf life
W66053002SOL. INJ. IN SERINGA PREUMPLUTA75mg/0,5mlCutie cu 2 seringi preumplute din sticla, cu ac fixat intr-un sistem de protectie automata a acului x 0,5 ml sol. inj. (75 mg risankizumab)PR1361/2019/012 ani
W67699001SOL. INJ. IN SERINGA PREUMPLUTA150mg/1mlCutie cu o seringa preumpluta din sticla, cu ac deja fixat si teaca pentru ac, integrate intr-un sistem de protectie automata a aculuiPR1361/2019/032 ani
W67700001SOL. INJ. IN STILOU INJECTOR PREUMPLUT150mg/1mlSeringa preumpluta din sticla, asamblata într-un stilou injector preumplut prevazut cu un sistem de protectie automata a aculuiPR1361/2019/022 ani
W69348001CONC. PT. SOL. PERF.60 mg/mlCutie cu un flacon x10ml concentrat pentru solutie perfuzabilaPR1361/2019/0424 luni
W69349001SOL INJ. IN CARTUS150 mg/mlCutie cu un cartus + un dispozitiv injector atasabil la nivelul corpuluiPR1361/2019/0524 luni
W70468001SOL INJ. IN CARTUS150mg/mlCutie cu 1 cartus + un dispozitiv injector atasabil la nivelul corpuluiPR1361/2019/072 ani
W72064001SOL. INJ. IN SERINGA PREUMPLUTA55mg/037mlCutie cu 1 seringa preumpluta din sticla, cu ac fixat intr-un sistem de protectie automata a acului x 0,37 ml sol. inj. (55 mg risankizumab)PR1361/2019/102 ani

What it is used for

The official indications for Risankizumab, quoted from the European Medicines Agency and the US FDA, are on Risankizumab in Anpheros Search.

The package leaflet and the summary of product characteristics are published by ANMDMR: search for “Skyrizi” in the national register.

Scan the box in Anpheros

In the Anpheros Daily app, photograph the medicine box: the app reads the name and strength, matches them against this register and adds the medicine to your list, with its code. From your list you can come back to this page.

Get the app

Source: ANMDMR — National Agency for Medicines and Medical Devices of Romania, Nomenclatorul medicamentelor de uz uman (register updated 29 October 2026). Shown as published, in Romanian where the register is in Romanian.